$13.26 -0.04 (%) Ironwood Pharmaceuticals Inc - NASDAQ

Oct. 24, 2014 | 04:00 PM

Partner Headlines

  1. Ironwood Presents IW-9179 Phase IIa Data At American College Of Gastroenterology 2014 Annual Scientific Meeting

    Benzinga | Oct. 20, 2014 | 08:09AM EST
  2. Ardelyx Bowel Drug Could Rival Actavis' Linzess

    IBD | Oct. 1, 2014 | 12:10PM EST
  3. Markets Open Higher; VeriFone Profit Tops Street View

    Benzinga | Sep. 4, 2014 | 11:31AM EST
  4. Benzinga's Top Downgrades

    Benzinga | Sep. 4, 2014 | 08:57AM EST
  5. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga | Jun. 10, 2014 | 11:04AM EST
  6. Ironwood Pharmaceuticals Announces $150M Proposed Public Offering of Common Stock

    Benzinga | Feb. 10, 2014 | 16:12PM EST
  7. Mid-Day Market Update: Dow Tumbles Over 100 Points; Signature Bank Shares Gain On Strong Earnings

    Benzinga | Jan. 21, 2014 | 12:58PM EST
  8. Mid-Morning Market Update: Markets Mixed; Verizon Posts Q4 Profit

    Benzinga | Jan. 21, 2014 | 10:56AM EST
  9. Weekly 3-Year Low Highlight: EXC, RVBD, IRWD, SHOS

    GuruFocus | Oct. 27, 2013 | 16:50PM EST
  10. UPDATE: Cowen & Company Upgraded Ironwood Pharmaceuticals

    Benzinga | Oct. 24, 2013 | 15:14PM EST
  11. Five-Year Lows: Singapore Airlines Limited, Gold Field Ltd., Ironwood Pharmaceuticals Inc. ...

    GuruFocus | Oct. 22, 2013 | 11:04AM EST
  12. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 22, 2013 | 10:13AM EST
  13. Earnings Scheduled For January 15, 2013

    Benzinga | Jan. 14, 2013 | 19:06PM EST
  14. Ironwood Starts Phase I Trial of Anti-Anxiety Drug in US

    Benzinga | Dec. 20, 2012 | 23:36PM EST
  15. Weekly CEO Buys Highlight: GDOT, VOCS, PES, IRWD, ABR

    GuruFocus | Nov. 11, 2012 | 14:31PM EST
  16. Ironwood Pharmaceuticals, Inc. (IRWD) CEO Peter M Hecht buys 50,000 Shares

    GuruFocus | Nov. 6, 2012 | 10:41AM EST
  17. Ironwood and AstraZeneca Announce Linaclotide Collaboration for China

    Benzinga | Oct. 23, 2012 | 03:13AM EST
  18. Ironwood and Forest Announce FDA Approval of LINZESSTM

    Benzinga | Aug. 30, 2012 | 08:01AM EST
  19. UPDATE: Cantor Fitzgerald Raises PT to $8 on Ironwood Pharmaceuticals; Maintains Sell

    Benzinga | Aug. 20, 2012 | 04:51AM EST
  20. Biotechs With Upcoming PDUFA Dates

    Benzinga | Jul. 18, 2012 | 09:09AM EST
  21. UPDATE: Wedbush Downgrades Ironwood Pharmaceuticals; Lowers PT

    Benzinga | Mar. 5, 2012 | 02:39AM EST
  22. Bank of America: Zelnorm vs. linaclotide

    Benzinga | Mar. 5, 2012 | 01:46AM EST
  23. Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

    Benzinga | Feb. 13, 2012 | 02:14AM EST
  24. From Earlier: Ironwood Pharmaceuticals Prices Public Offering of 5.25M Shares at $15.09

    Benzinga | Feb. 10, 2012 | 00:18AM EST
  25. Ironwood Pharmaceuticals Announces Proposed Public Offering of 5.25M Shares

    Benzinga | Feb. 8, 2012 | 09:57AM EST
  26. Ironwood Pharmaceuticals and Bionomics Announce Collaboration, Research, and License Agreement

    Benzinga | Jan. 4, 2012 | 10:01AM EST
  27. European Patent Office Upholds Synergy Pharmaceuticals' Grant of Claims to Plecanatide

    Benzinga | Jan. 3, 2012 | 23:52PM EST
Trading Center